Royal Bank of Canada
STIM icon

Royal Bank of Canada’s Neuronetics STIM Stock Holding History

Royal Bank of Canada’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$140K Buy
95,848
+48,615
+103% +$77.1K ﹤0.01% 4936
2025
Q4 		$65K Buy
47,233
+7,099
+18% +$14.9K ﹤0.01% 5415
2025
Q3 		$110K Buy
40,134
+39,935
+20,068% +$142K ﹤0.01% 5463
2025
Q2 		$1K Buy
199
+170
+586% +$671 ﹤0.01% 6933
2025
Q1 		$0 Hold
29
– – ﹤0.01% 7211
2024
Q4 		$0 Sell
29
-641
-96% -$666 ﹤0.01% 7236
2024
Q3 		$1K Sell
670
-2,173
-76% -$2.85K ﹤0.01% 6745
2024
Q2 		$5K Buy
+2,843
New +$8.2K ﹤0.01% 6555
2023
Q3 		– Sell
-1,377
Closed -$3K – 7561
2023
Q2 		$3K Buy
+1,377
New +$3.34K ﹤0.01% 6804
2023
Q1 		– Sell
-144,502
Closed -$993K – 7455
2022
Q4 		$993K Sell
144,502
-1,669
-1% -$7.88K ﹤0.01% 3500
2022
Q3 		$465K Sell
146,171
-5,934
-4% -$21.6K ﹤0.01% 4095
2022
Q2 		$488K Sell
152,105
-18,728
-11% -$54.4K ﹤0.01% 4114
2022
Q1 		$518K Buy
170,833
+64,983
+61% +$220K ﹤0.01% 4242
2021
Q4 		$472K Buy
105,850
+45,490
+75% +$223K ﹤0.01% 4518
2021
Q3 		$396K Buy
60,360
+17,451
+41% +$167K ﹤0.01% 4543
2021
Q2 		$687K Buy
42,909
+3,972
+10% +$54.9K ﹤0.01% 3986
2021
Q1 		$482K Buy
38,937
+38,926
+353,873% +$597K ﹤0.01% 4219
2020
Q4 		$0 Sell
11
-5,145
-100% -$38.7K ﹤0.01% 7277
2020
Q3 		$25K Buy
5,156
+3,811
+283% +$14.5K ﹤0.01% 5612
2020
Q2 		$3K Sell
1,345
-2,375
-64% -$4.87K ﹤0.01% 6211
2020
Q1 		$7K Buy
3,720
+488
+15% +$1.53K ﹤0.01% 5950
2019
Q4 		$15K Buy
3,232
+727
+29% +$4.52K ﹤0.01% 5994
2019
Q3 		$21K Hold
2,505
– – ﹤0.01% 5491
2019
Q2 		$31K Hold
2,505
– – ﹤0.01% 5501
2019
Q1 		$38K Buy
2,505
+2,481
+10,338% +$41K ﹤0.01% 5324
2018
Q4 		$0 Sell
24
-201
-89% -$4.41K ﹤0.01% 7095
2018
Q3 		$7K Buy
+225
New +$6.84K ﹤0.01% 6123

Other funds holding STIM

MAM
Madryn Asset Management New York $34.1M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada's STIM Position: Q1 2026 in Review

Royal Bank of Canada increased its Neuronetics (STIM) stake by 103% in Q1 2026, buying an estimated $77.1K and bringing the position to 95,848 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #4936.

Royal Bank of Canada first reported a position in STIM in Q3 2018 and has held it in 27 quarters since. The position peaked at $993K in Q4 2022. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • Royal Bank of Canada held 95,848 shares of Neuronetics worth $140K as of Q1 2026.
  • Royal Bank of Canada bought 48,615 Neuronetics shares in Q1 2026, an estimated $77.1K.
  • Neuronetics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4936 holding.
  • Royal Bank of Canada first reported a position in Neuronetics in Q3 2018 and has held it in 27 quarters since.
  • Royal Bank of Canada's Neuronetics position peaked at $993K in Q4 2022.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.